Alnylam Pharma (ALNY) Tops Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $251.65 +3.00%
EPS Growth %: -39.0%
Financial Fact:
Net revenues from research collaborators: 8.71M
Today's EPS Names:
NEOV, MANU, CTAS, More
EPS Growth %: -39.0%
Financial Fact:
Net revenues from research collaborators: 8.71M
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q1 EPS of ($1.25), $0.01 better than the analyst estimate of ($1.26). Revenue for the quarter came in at $19 million versus the consensus estimate of $23.65 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Jefferies Starts China Oilfield Services (2883:HK) (CHOLF) at Buy
- JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
